Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study.
about
Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapyCardiotoxicity in childhood cancer survivors: strategies for prevention and managementCurrent Views on Anthracycline Cardiotoxicity in Childhood Cancer SurvivorsDexrazoxane does not protect against doxorubicin-induced damage in young ratsExperiments and synthesis of bone-targeting epirubicin with the water-soluble macromolecular drug delivery systems of oxidized-dextran.Effect of dexrazoxane and amifostine on the vertebral bone quality of Doxorubicin treated male ratsEndophytic Actinobacteria Associated with Dracaena cochinchinensis Lour.: Isolation, Diversity, and Their Cytotoxic ActivitiesBeneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis.Increased health care utilization by survivors of childhood lymphoblastic leukemia is confined to those treated with cranial or total body irradiation: a case cohort studyRisks and diagnosis of coronary artery disease in Hodgkin lymphoma survivorsCardiovascular disease in adult survivors of childhood cancer.Exercise training in childhood cancer survivors with subclinical cardiomyopathy who were treated with anthracyclinesVascular injury in cancer survivors.Dexrazoxane for the treatment of chemotherapy-related side effects.Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant PatientCardiac function in long-term survivors of childhood lymphoma.Cardiovascular toxicities from systemic breast cancer therapy.Anthracycline cardiotoxicity: prevalence, pathogenesis and treatmentChemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis.Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.Cohort Profile: the French childhood cancer survivor study for leukaemia (LEA Cohort).NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivorsCardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohortAnalysis of proteome changes in doxorubicin-treated adult rat cardiomyocyte.Cardiac toxicity of high-dose chemotherapy.A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.Echocardiographic Detection of Cardiac Dysfunction in Childhood Cancer Survivors: How Long Is Screening Required?The differential effects of green tea on dose-dependent doxorubicin toxicity.Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways.Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclinesNeurocognitive function and CNS integrity in adult survivors of childhood Hodgkin Lymphoma - a commentary on report from Krull and colleaguesCancer cell response to anthracyclines effects: mysteries of the hidden proteins associated with these drugsImpaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors.Laboratory monitoring in oncology.Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional StudyRisk factors for anthracycline-associated cardiotoxicity.Successful coordination and execution of nontherapeutic studies in a cooperative group setting: lessons learned from Children's Oncology Group studies.Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.Characteristics of patients with haematological and breast cancer (1996-2009) who died of heart failure-related causes after cancer therapy.Towards a Model-Based Dose Recommendation for Doxorubicin in Children.
P2860
Q24240568-10B080C7-0875-4C11-A797-C9C4F8EC3D9CQ24628695-A9CE4760-FEDA-46DD-8945-6CE9B36AB7C5Q28083073-3A7FC955-4FAB-4EB2-BB0F-7F5210B242DCQ28572861-9BF47F03-9896-40A6-B9A5-3CE6377C20C7Q30729687-12AEB0B6-F1A1-4D79-BFDF-974063CCC575Q33455575-415941C0-A4FA-45F8-B856-299C87F3ABDEQ33581870-5582D2A6-8157-457A-8AA6-EBB7D083BA2FQ33615969-B0A76604-83C9-4487-A0EF-BD1EA170E30AQ33761036-07BBF91A-E463-4460-AD87-A892ED44E90FQ33948488-555B5CAD-BC9B-4B12-BAC4-256C71AA064EQ34042984-C0A0C130-2F34-467C-963F-38A9DC8CB131Q34205317-E7973A9D-C486-4611-AD50-05E25AAB749BQ34211238-CA17CEEF-D8A4-4315-BB69-4E79412AE930Q34211957-2075BF1D-7044-4602-87EC-8FE287CBEEDFQ34522746-B4093BA0-3852-4819-A3BD-3389B93CB45BQ34557579-A849DCAA-C52D-49A0-B55A-53EF88A44854Q34630349-E1F2BF7A-0CC4-4E8C-8D30-2528A097970DQ34639876-667D66BD-0799-4176-A9D2-16CC3EAF0842Q34659375-658C825F-C0E1-4B8E-9235-FDD1FA8C91E3Q35076156-BF85DA3A-D50B-4FC4-B9AA-7558DAADCC9DQ35119306-F11306ED-C524-42A3-B383-31C3F40C2CBEQ35557142-24C296A8-1640-405F-8CAA-7C17E362AE40Q35699184-993014AA-F626-476E-80E6-4A67737F0B97Q35816653-FA0B7469-93AA-40A4-9CDB-224048AC463EQ35949084-E8E319F1-ABBC-4392-B3EF-8D7F3DF3E61AQ36004460-EB522304-E58B-4663-B5FD-1601D86B7476Q36348525-1E09B2C8-3915-4623-8EAC-C9A9421B8F4AQ36398643-061DF9ED-52F3-437B-B49D-88B01F7E66FDQ36413425-CA6CEE05-95F0-44BC-8EC2-D32C0386DA96Q36416745-5C78BA0E-1B6B-4931-B455-B5742BF11994Q36508274-B7E762E0-0AB2-47B2-8EA6-726D5B0948B5Q36538243-FF9AB823-062D-4791-A44E-FDC896C63B30Q36649653-61A36C50-C56A-44E5-A26A-297E9F5A9EC1Q36677751-51FFB0A9-E769-4B35-810B-6D545DBD3F72Q36732654-0620ED19-FD4A-4BD3-899C-2B83ACC9F6EDQ36921775-454A1A7D-C0C6-4171-B074-FC7CC410DC77Q36990089-6846013B-9E78-45BD-92F8-719FD717EF45Q37059896-3B9AFA0F-541B-4327-B2DA-A7D2C3B46B0CQ37411949-1F3418E3-75A0-404B-AD13-0592D5C822F4Q37650674-E6960400-BAA1-4C54-BFBB-518303B7F429
P2860
Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Anthracycline-induced clinical ...... en: long-term follow-up study.
@ast
Anthracycline-induced clinical ...... en: long-term follow-up study.
@en
type
label
Anthracycline-induced clinical ...... en: long-term follow-up study.
@ast
Anthracycline-induced clinical ...... en: long-term follow-up study.
@en
prefLabel
Anthracycline-induced clinical ...... en: long-term follow-up study.
@ast
Anthracycline-induced clinical ...... en: long-term follow-up study.
@en
P2093
P1476
Anthracycline-induced clinical ...... ren: long-term follow-up study
@en
P2093
E C van Dalen
J Ottenkamp
L C Kremer
P304
P356
10.1200/JCO.2001.19.1.191
P407
P577
2001-01-01T00:00:00Z